| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Relmada Therapeutics, Inc. (RLMD) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. RLMD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.30M | $9.52M | - | |
| COO | 828.0K | $6.06M | - | |
| Other | 828.0K | $6.06M | - | |
| CFO | 800.0K | $5.86M | - | |
| Dir | 164.0K | $1.20M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 9, 2021 | Kelly Paul Edward53 | Director | Sale+OE | 5,000 | $35.71 | $178,550.89 | -1.5% | |
| Mar 1, 2021 | Casamento Charles J71 | Director | Sell | 3,000 | $33.87 | $101,617.80 | -15.8% | |
| Feb 24, 2021 | Traversa Sergio55 | CEO | Sale+OE | 10,000 | $34.24 | $342,392.06 | -3.5% | |
| Feb 24, 2021 | Shenouda Maged | CFO | Sale+OE | 3,000 | $34.18 | $102,529.24 | -33.9% | |
| Feb 24, 2021 | Kelly Paul Edward53 | Director | Sale+OE | 5,000 | $34.19 | $170,933.00 | -1.0% | |
| Feb 11, 2021 | Traversa Sergio55 | CEO | Sale+OE | 1,446 | $35.43 | $51,238.43 | -1.6% | |
| Feb 11, 2021 | Shenouda Maged | CFO | Sale+OE | 1,428 | $35.39 | $50,542.06 | -39.1% | |
| Feb 10, 2021 | Traversa Sergio55 | CEO | Sale+OE | 11,206 | $35.17 | $394,084.66 | -3.9% | |
| Feb 10, 2021 | Shenouda Maged | CFO | Sale+OE | 11,372 | $35.17 | $399,910.17 | -40.3% | |
| Feb 9, 2021 | Kelly Paul Edward53 | Director | Sale+OE | 3,569 | $35.18 | $125,564.52 | -1.1% |